4
Changes in Ownership
NEUROONE MEDICAL TECHNOLOGIES Corp Filed Acc 0001709738-23-000016
Business Development Director sold 38,293 shares at an average $1.44 ($55,129)
From the SEC's structured data for this filing
Trades in this filing
Christianson Mark · Business Development Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-26 | Sale : show line 1 in the form | −6,848 | $1.35 | $9,269 | 332,039 | D |
| 2023-12-27 | Sale : show line 2 in the form | −31,445 | $1.46 | $45,859 | 300,594 | D |
| Open-market sales · 38,293 sh · avg $1.44 · $55,129 | ||||||
Loading xslF345X05/primary_doc.xml…